2,887
Views
6
CrossRef citations to date
0
Altmetric
Review Articles

Human studies on probiotics: Aspects of scientific documentation

(Prof)
Pages 8-12 | Published online: 13 Dec 2016

  • Salminen S, Bouley MC, Boutron-Rualt MC, Cummings J, Franck A, Gibson G, Isolauri E, Moreau M-C, Roberfroid M, Rowland!: Functional food science and gastrointestinal physiology and function. Br J Nutr 1998;Suppl 1;S147-S171.
  • Diplock AT, Aggett P. Ashwell M, Bornet F, Fern, Roberfroid M: Scientific concepts of functional foods in Europe: consensus document. Br I Nutr 1999:81:Suppl 1:S1–S27.
  • Tuomola E, Crittenden R, Playne M, Isolauri E, Salminen S: Quality assurance criteria for probiotic bacteria. Am J Clin Nutr 2001; 73: 3935–85.
  • Salminen S, Ouwehand A, Benno Y, Lee Y-K: Probiotics: how should they be defined? Trends in Food Science and Technology 1999; 10: 1–4.
  • Sandstrom B. Quality criteria in human experimental nutrition research. Eur J Clin Nutr 1995; 49: 315–22.
  • De Roos N, Katan M: Effects of probiotic bacteria on diarrhoea, lipid metabolism, and carcinogenesis: a review of papers published between 1988 and 1998. Am J Clin Nutr 2000; 71: 405–11.
  • Pathmakanthan S, Meance S, Edwards CA: Probiotics: A review of human studies to date and methodological aspects. Micr Ecol Health Dis. 2000:Suppl 2: 10-30.
  • McFarland L. A review of the evidence of health claims for biotherapeutic agents. Micr Ecol Health Dis 2000: 12:65–76.
  • Fondén R, Mogensen G, Tanaka R, Salminen S: Culture-containing dairy products - effect on intestinal microflo a, human nutrition and health - current knowledge and future perspectives. Bull Intern1 Dairy Fed 2000:352.
  • de Vrese, Stegelmann A, Richter B, Fenselau S, Laue C, Schrezenmeir J: Probiotics - compensation for lactase insufficiency. Am J Clin Nutr 2001 ; 73: S421-9S
  • Sanders ME, Walker DC, Walker KM, Aoyama K, Klaenhammer TR: Performance of commercial cultures in fluid milk applications. J Dairy Sci 1996; 79: 943–55.
  • Majamaa H, Isolauri E, Saxelin M, Vesikari T: Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J Pediatr Gastroenterol Nutr 1995; 20: 333–8.
  • Guandalini S, Pensabene L, Zikri MA, Dias J. et al.: Lactobacillus GG administered in oral rehydration solution to children with acute diarrhoea: a multicenter European trial. J Ped Gastroenterol Nutr 2000: 30:54–60.
  • Kaila M, Isolauri E, Saxelin M, Arvilommi H, Vesikari T: Viable versus inactivated Lactobacillus strain GG in acute rotavirus diarrhoea. Arch Dis Child l995:72:5 1-3.
  • Saavedra JM, Bauman NA, Oung I, Perman JA, Yolken RH: Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. The Lancet 1994; 344: 1046–9.
  • Simakachorn N, Pichaipat V, Ritchipornpaisarn, Kongkaew C, Tongpradit P, Varavithya W: Clinical evaluation of the addition of lyophilized, heatkilled Lactobacillus acidophilus LB to oral rehydration therapy in the treatment of acute diarrhoea in children. Ped Gastroenterol Nutr 2000: 30: 68–72.
  • Siitonen S, Vapaatalo H, Salminen S, Gordin A, Saxelin M, Wikberg R, Kirkkola A-M: Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhoea. Ann Med 1990,2257–60.
  • Arvola T, Laiho K, Torkkeli S, Mykkanen H, Salminen S, Maunula I, Isolauri E: Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhoea in children with respiratory infections: a randomized study. Pediatrics 1999; 104:64.
  • Vanderhoof J, Whitney D, Antonson D, Hanner T, Lupo J, Young R. Lactobacillus GG in the prevention of antibiotic associated diarrhoea in children. J Pediatr 1999: 135: 564–8.
  • Marteau P, de Vrese M, Cellier C, Schrezenmeir J: Protection from gastrointestinal diseases with the use of probiotics. Am J Clin Nutr 2001; 73: 43OS-6s.
  • Pochapin M: The effect of probiotics on Clostridium dificile diarrhoea. Am J Gastroenterol 2OOO;95: 11S-13S.
  • Black FT, Einarsson K., Lidbeck A, Orrhage K, Nord C: Effects of lactic acid producing bacteria on the human intestinal microflora during ampicillin treatment. Scand J Infect Dis 1991; 23: 247–54.
  • Isolauri E, Arvola T, Siitas Y, Moilanen E, Salminen S: Probiotics in the management of atopic eczema. Clin Experiml Allergy 2000:30: 1605–10.
  • Kirjavainen P, Apostolou E, Salminen S, Isolauri E: New approaches of probiotics - a novel approach in the management of food allergy. Allergy l999; 54: 909-15.
  • Kalliomaki M, Kirjavainen P, Eerola E, Kero P, Salminen S, Isolauri E: Distinct patterns of neonatal gut microflora in infants developing or not developing atopy. Submitted to J Allergy and Clin Irnmunol. 200 1 ; 107: 129-34.
  • Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E: Probiotics in the prevention of atopic diseases: a randomised placebocontrolled trial. The Lancet 2001 ;357: 1076–9.
  • Wollowski I, Rechkemmer G, Pool-Zobel B: Protective role of probiotics and prebiotics in colon cancer. Am J Clin Nutr 2001; 73: 451S-6S.
  • Bums A, Rowland 1:Anti-carcinogenicity of probiotics andprebiotics. Curr Issues Intesti Microbial 2000; 1: 13–24.
  • Aso Y, Akazan H: Prophylactic effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer. Urol Int 1992; 49: 125–9.
  • Aso Y, Akaza H, Kotake T, Tsukamoto T, Imai K, Naito S : Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial. Eur Urol 1995; 27: 104–9.
  • Ohashi Y. Case Control study for bladder cancer prevention: habitual intake of lactic acid bacteria prevents occurrence of bladder cancer. Proceedings of 2nd International Congress on Probiotics, Guadalajara, Mexico, 2000.
  • von H, Holst H, Grobara P, Wiedermann G: Prophylaxe des Reisediarrhoe mit Saccharomyces boulardii. (Prevention of traveller's diarrhoea by Saccharomyces boulardii). Fortschritte der Medizin 1993; 11 1 : 153-6. ????
  • Midolo P, Lambert J, Hull R, Luo F, Grayson M: In vitro inhibition of Helicobacterpylori NCTC 1 1637 by organic acids and lactic acid bacteria. J Appl Bacteriol 1995; 79: 475–9.
  • Mitchetti P, Dorta G, Wiesel P, Brassart D, Wedu E, Herman M, Felley C, Porta N, Rouvet M, Blum A, Corthesy-Theulan I: Effect of whey based supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans. Digestion l999: 60:203-9.
  • Bazzoli F, Zagari R, Fossi S et al.: In vivo Helicobacter pylori clearance failure with Lactobacillus acidophilus. Gastroenterology 1992; 102:A38.
  • Canducci F et al.:A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates" by Aliment Pharmacol Ther 2000; 14: 1625–9.
  • Benno Y, Mitsuoka T: Development of intestinal microflora in humans and adults. Bifidobacteria Microflora 1986; 5: 13–25.
  • Steidler L, Hans W, Schotte L, Neirynck S, Obermeier F, Falk W, Fiers W, Remaut E: Treatment of murine colitis by Lactococcus lactis secreting interleukin- 10. Science 2000; 289: 1352–3.
  • Hooper L, Wong M, Thelin A, Hansson L, Falk P, Gordon J: Molecular analysis of commensal host-microbial relationships in the intestine. Science 2001 ;29 1 :88 1-4.